# ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

> **NCT00168168** · NA · COMPLETED · sponsor: **Alberta Health services** · enrollment: 60 (—)

## Conditions studied

- Peripheral Stem Cell/Marrow Transplant

## Interventions

- **DRUG:** G-CSF/Filgrastim

## Key facts

- **NCT ID:** NCT00168168
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 60 (—)
- **Last updated:** 2010-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168168, "ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00168168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*